A1.02 Detecting AD markers in blood samples

A device for detecting protein biomarkers of Alzheimer's disease (AD) by analyzing the optical signature of blood samples and other peripheral fluids using artificial intelligence (AI) algorithms. The product will include the functionalization of plasmonic surfaces to specifically recognize the target molecules and refine the spectroscopy signals acquired.

Date Start

Jan. 2, 2023

Date End

Dec. 31, 2025

Achievement Rate

Last Update: Oct. 15, 2024

Technology Owner